| Dr Douglas D Abbott, MD | |
|
2265 Exchange St, Astoria, OR 97103-3331 | |
| (503) 338-4075 | |
| (503) 338-4076 |
| Full Name | Dr Douglas D Abbott |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 28 Years |
| Location | 2265 Exchange St, Astoria, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508892605 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XX0005X | Orthopaedic Surgery - Sports Medicine | MD150601 (Oregon) | Primary |
| 207X00000X | Orthopaedic Surgery | MD150601 (Oregon) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Home Health | Portland, OR | Home health agency |
| Harbors Home Health / Hospice | Hoquiam, WA | Home health agency |
| Columbia Memorial Hospital | Astoria, OR | Hospital |
| Ocean Beach Hospital | Ilwaco, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Columbia Lutheran Charities | 5294643359 | 78 |
News Archive
Cubist Pharmaceuticals, Inc. today announced that a trial date has been set for patent litigation in the U.S. District Court for the District of Delaware against Teva Parenteral Medicines, Inc. (TPM), Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd. alleging infringement of Cubist's US Patent Nos. 6,468,967 and 6,852,689, which expire on September 24, 2019, and US Patent No. RE39,071, which expires on June 15, 2016.
Researchers from Canada and the United States today told attendees of the Experimental Biology 2011 Scientific Meeting that they have uncovered a possible means of enabling women to favorably influence whether the estrogens in their bodies take a "beneficial path" or a "disease-potential" path.
Scientists have identified a channel present in many pain detecting sensory neurons that acts as a 'brake', limiting spontaneous pain. It is hoped that the new research, published today [22 January] in the Journal of Neuroscience, will ultimately contribute to new pain relief treatments.
Principle Investigator HARUNO Masahiko and Dr. MORI Kazuma at the Center for Information and Neural Networks, the National Institute of Information and Communications Technology (NICT, President: TOKUDA Hideyuki, Ph.D.), report the use of machine learning to analyze behavior on Twitter and predict a wide range of personality traits and attributes such as intelligence and extraversion.
› Verified 9 days ago
| Entity Name | Columbia Lutheran Charities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134146939 PECOS PAC ID: 5294643359 Enrollment ID: O20040202000073 |
News Archive
Cubist Pharmaceuticals, Inc. today announced that a trial date has been set for patent litigation in the U.S. District Court for the District of Delaware against Teva Parenteral Medicines, Inc. (TPM), Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd. alleging infringement of Cubist's US Patent Nos. 6,468,967 and 6,852,689, which expire on September 24, 2019, and US Patent No. RE39,071, which expires on June 15, 2016.
Researchers from Canada and the United States today told attendees of the Experimental Biology 2011 Scientific Meeting that they have uncovered a possible means of enabling women to favorably influence whether the estrogens in their bodies take a "beneficial path" or a "disease-potential" path.
Scientists have identified a channel present in many pain detecting sensory neurons that acts as a 'brake', limiting spontaneous pain. It is hoped that the new research, published today [22 January] in the Journal of Neuroscience, will ultimately contribute to new pain relief treatments.
Principle Investigator HARUNO Masahiko and Dr. MORI Kazuma at the Center for Information and Neural Networks, the National Institute of Information and Communications Technology (NICT, President: TOKUDA Hideyuki, Ph.D.), report the use of machine learning to analyze behavior on Twitter and predict a wide range of personality traits and attributes such as intelligence and extraversion.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Douglas D Abbott, MD 2265 Exchange St, Astoria, OR 97103-3331 Ph: (503) 338-4075 | Dr Douglas D Abbott, MD 2265 Exchange St, Astoria, OR 97103-3331 Ph: (503) 338-4075 |
News Archive
Cubist Pharmaceuticals, Inc. today announced that a trial date has been set for patent litigation in the U.S. District Court for the District of Delaware against Teva Parenteral Medicines, Inc. (TPM), Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd. alleging infringement of Cubist's US Patent Nos. 6,468,967 and 6,852,689, which expire on September 24, 2019, and US Patent No. RE39,071, which expires on June 15, 2016.
Researchers from Canada and the United States today told attendees of the Experimental Biology 2011 Scientific Meeting that they have uncovered a possible means of enabling women to favorably influence whether the estrogens in their bodies take a "beneficial path" or a "disease-potential" path.
Scientists have identified a channel present in many pain detecting sensory neurons that acts as a 'brake', limiting spontaneous pain. It is hoped that the new research, published today [22 January] in the Journal of Neuroscience, will ultimately contribute to new pain relief treatments.
Principle Investigator HARUNO Masahiko and Dr. MORI Kazuma at the Center for Information and Neural Networks, the National Institute of Information and Communications Technology (NICT, President: TOKUDA Hideyuki, Ph.D.), report the use of machine learning to analyze behavior on Twitter and predict a wide range of personality traits and attributes such as intelligence and extraversion.
› Verified 9 days ago
Dr. Benjamin Sherman, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2265 Exchange St, Astoria, OR 97103 Phone: 503-338-4075 |